Furthermore, upregulated expression of the tumor-suppressive miR-34a was found to directly inhibit MARCKS in a sequence-specific manner and decreased the viability of drug-resistant cells upon treatment with MM-associated chemotherapeutic agents. This evidence concerns the gene MARCKS and neoplasm.